The global market for DNA Sequencing is estimated at US$7.8 Billion in 2023 and is projected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing.
Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.
The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing.
Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the DNA Sequencing Consumables segment, which is expected to reach US$7.5 Billion by 2030 with a CAGR of a 11.5%. The DNA Sequencing Instruments segment is also set to grow at 10.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.1 Billion in 2023, and China, forecasted to grow at an impressive 15.9% CAGR to reach $2.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global DNA Sequencing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global DNA Sequencing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global DNA Sequencing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Eppendorf AG, Adaptive Biotechnologies Corporation, Cofactor Genomics, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 76 Featured):
- Eppendorf AG
- Adaptive Biotechnologies Corporation
- Cofactor Genomics, Inc.
- Annoroad Gene Technology
- ADS Biotec, Inc.
- BGI Genomics Co Ltd.
- DayTwo
- Dynasty Gene
- Clevergene
- Ares Genetics GmbH
- DDL Diagnostic Laboratory
- DelphiTest GmbH
- DNA link
- ARL Bio Pharma, Inc.
- Celgene Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned
- Eppendorf AG
- Adaptive Biotechnologies Corporation
- Cofactor Genomics, Inc.
- Annoroad Gene Technology
- ADS Biotec, Inc.
- BGI Genomics Co Ltd.
- DayTwo
- Dynasty Gene
- Clevergene
- Ares Genetics GmbH
- DDL Diagnostic Laboratory
- DelphiTest GmbH
- DNA link
- ARL Bio Pharma, Inc.
- Celgene Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 392 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 7.8 Billion |
| Forecasted Market Value ( USD | $ 17.1 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
